Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Share Price
$240.45
Market Cap
$579.46B
Change (1 day)
0.51%
Change (1 year)
46.88%
Country
US
Trade Johnson & Johnson (JNJ)

Category

Operating Margin for Johnson & Johnson (JNJ)
Operating Margin as of March 2026 TTM: 27.17%
According to Johnson & Johnson latest financial reports and stock price the company's current Operating Margin (TTM) is 27.17%. At the end of 2024 the company had an Operating Margin of 24.94%.
Operating Margin history for Johnson & Johnson from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 27.17% 0.00%
2025 27.17% 8.94%
2024 24.94% -9.28%
2023 27.49% 3.35%
2022 26.60% 11.34%
2021 23.89% -6.50%
2019 25.55% -1.58%
2018 25.96% 5.02%
2017 24.72% -5.29%
2016 26.10% -8.23%
2014 28.44% 7.00%
2013 26.58% 4.89%
2012 25.34% -5.59%
2011 26.84% -0.30%
2010 26.92% 6.15%
2008 25.36% 1.85%
2007 24.90% -3.15%
2006 25.71% -1.49%
2005 26.10% 0.50%
2003 25.97% -2.59%
2002 26.66% 9.26%
2001 24.40% 7.58%
2000 22.68% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
45.56% -98.32%
US
26.72% -99.02%
US
31.24% -98.85%
CH
23.28% -99.14%
GB
41.19% -98.48%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.